KELLY MICHAEL GERALD 4
4 · RENOVIS INC · Filed Feb 4, 2008
Insider Transaction Report
Form 4
RENOVIS INCRNVS
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
- Award
Stock Options (right to buy)
2008-01-31+100,000→ 100,000 totalExercise: $2.62Exp: 2018-01-30→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Shares vest as follows: 1/3rd of the shares vest on January 31, 2009 and the remaining vest 1/3rd annually over the next 2 years.